Donenberg Phillip B. bought TSHA
June 1, 2026 · Form 4 insider transaction
Donenberg Phillip B. bought 42,671 shares of Taysha Gene Therapies, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
42,671
Price
$0.00
Total value
N/A
InsiderDonenberg Phillip B.
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after42,671
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.